|Bid||2.00 x 1300|
|Ask||7.79 x 1100|
|Day's Range||6.47 - 6.76|
|52 Week Range||5.64 - 11.35|
|Beta (3Y Monthly)||0.65|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of 1.45% and -11.56%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 68 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks ...
Often, publicly-traded companies that trade in discount-bin valuations are there for a reason. When it becomes clear that success is no longer probable, astute investors bail, leaving others holding the bag.
The Cambridge, Massachusetts-based company said it had a loss of 69 cents per share. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Seres Therapeutics, Inc. Here are 5 ETFs with the largest exposure to MCRB-US. Comparing the performance and risk of Seres Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Seres Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 17 cents. The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks ...